Literature DB >> 2760994

Recognition and management of Budd-Chiari syndrome: report of one hundred cases.

Z G Wang1, Y Zhu, S H Wang, L P Pu, Y H Du, H Zhang, C Yuan, Z Chen, M L Wei, L Q Pu.   

Abstract

Budd-Chiari syndrome is an unusual form of portal hypertension caused by occlusion of the hepatic venous outflow, and it is often confused with portal hypertension caused by liver cirrhosis. Its prognosis is poor, and optimal therapy remains to be established. This is a report of 100 confirmed cases of this syndrome treated from December 1982 to March 1988 at two vascular centers in China. Sixty-two male and 38 female patients, 15 to 62 years of age (mean age, 32.6 years) were treated. Seventy-six patients had intractable ascites, 56 had esophageal varices, and 22 had upper gastrointestinal bleeding. There were 37 cases of membranous obstruction, 57 cases of occlusion of the inferior vena cava above the confluence of the hepatic veins, and 6 cases of occlusion of the hepatic veins. Eighty-one patients were operated on. Operative mortality rate was 8.6% (7/81). Follow-up from 2 to 66 months revealed that 58 of the patients operated on (72%) had good results, whereas 11 of 19 (58%) patients treated nonoperatively died within 2 months after admission. On the basis of these data we conclude that the operative procedure must be tailored to the cause and underlying pathologic characteristics. Mesoatrial shunting is the operation of choice for patients with occlusion of the retrohepatic inferior vena cava and hepatic veins, and inferior vena cava--atrial shunting is the operation of choice for patients with occlusion of the inferior vena cava and patency of the hepatic veins. Membranotomy is used for patients with inferior vena cava webbing, and mesocaval shunting is used for patients with intrahepatic venous occlusion only.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1989        PMID: 2760994

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  11 in total

1.  Budd-Chiari syndrome revisited: 38 years' experience with surgical portal decompression.

Authors:  Marshall J Orloff; Jon I Isenberg; Henry O Wheeler; Pat O Daily; Barbara Girard
Journal:  J Gastrointest Surg       Date:  2011-11-08       Impact factor: 3.452

2.  To restrict indication for stenting of the inferior vena cava and liver transplantation in patients with Budd-Chiari syndrome.

Authors:  Zhonggao Wang
Journal:  Front Med China       Date:  2007-05-01

3.  A 27-year experience with surgical treatment of Budd-Chiari syndrome.

Authors:  M J Orloff; P O Daily; S L Orloff; B Girard; M S Orloff
Journal:  Ann Surg       Date:  2000-09       Impact factor: 12.969

4.  Supra Hepatic Inferior Vena Cava Thrombosis-Surgical Challenges.

Authors:  Senthil Muthuraman; Anand Ramamurthy; Mahesh Gopashetty; Cuddalore Sadasivam Vijayshankar; Anand Khakhar
Journal:  J Clin Diagn Res       Date:  2016-12-01

Review 5.  Budd-Chiari syndrome and liver transplantation.

Authors:  Nobuhisa Akamatsu; Yasuhiko Sugawara; Norihiro Kokudo
Journal:  Intractable Rare Dis Res       Date:  2015-02

6.  Portasystemic shunting versus liver transplantation for the Budd-Chiari syndrome.

Authors:  H Bismuth; D J Sherlock
Journal:  Ann Surg       Date:  1991-11       Impact factor: 12.969

7.  Current management of the Budd-Chiari syndrome.

Authors:  A S Klein; J V Sitzmann; J Coleman; F H Herlong; J L Cameron
Journal:  Ann Surg       Date:  1990-08       Impact factor: 12.969

8.  Changing spectrum of Budd-Chiari syndrome in India with special reference to non-surgical treatment.

Authors:  Deepak N Amarapurkar; Sundeep J Punamiya; Nikhil D Patel
Journal:  World J Gastroenterol       Date:  2008-01-14       Impact factor: 5.742

9.  Percutaneous hepatic venous reanastomosis in a patient with Budd-Chiari syndrome.

Authors:  B L Dolmatch; B S Cooper; P P Chang; R J Gray; K M Horton
Journal:  Cardiovasc Intervent Radiol       Date:  1995 Jan-Feb       Impact factor: 2.740

10.  Rapidly progressing Budd-Chiari syndrome complicated by hepatocellular carcinoma.

Authors:  Jeong Won Jang; Seung Kew Yoon; Si Hyun Bae; Jong Young Choi; Kyu Won Chung; Hee Sik Sun
Journal:  Korean J Intern Med       Date:  2003-09       Impact factor: 2.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.